Literature DB >> 27038371

Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.

Yeri Kim1, Joanne O Davidson2, Katherine C Gunn2, Anthony R Phillips3, Colin R Green1, Alistair J Gunn4.   

Abstract

Neurodegenerative, cardiovascular, and metabolic disorders, once triggered, share a number of common features, including sustained inflammatory cell activation and vascular disruption. These shared pathways are induced independently of any genetic predisposition to the disease or the precise external stimulus. Glial cells respond to injury with an innate immune response that includes release of proinflammatory cytokines and chemokines. Vascular endothelial cells may also be affected, leading to opening of the blood-brain barrier that facilitates invasion by circulating inflammatory cells. Inflammation can trigger acute neural injury followed by chronic inflammation that plays a key role in neurodegenerative conditions. Gap junction channels normally allow direct cell-to-cell communication. They are formed by the docking of two hemichannels, one contributed by each of the neighboring cells. While the opening probability of these channels is tightly controlled under resting conditions, hemichannels can open in response to injury or inflammatory factors, forming a large, relatively nonselective membrane pore. In this review, we consider the CNS immune system from the perspective that modulating connexin hemichannel opening can prevent tissue damage arising from excessive and uncontrolled inflammation. We discuss connexin channel roles in microglia, astrocytes, and endothelial cells in both acute and chronic inflammatory conditions, and in particular describe the role of connexin hemichannels in the inflammasome pathway where they contribute to both its activation and its spread to neighboring cells. Finally, we describe the benefits of hemichannel block in animal models of brain injury.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Cerebral ischemia; Connexin 43; Connexin hemichannels

Mesh:

Substances:

Year:  2015        PMID: 27038371     DOI: 10.1016/bs.apcsb.2015.12.001

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  25 in total

1.  Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease.

Authors:  Odunayo O Mugisho; Colin R Green; David M Squirrell; Sarah Bould; Helen V Danesh-Meyer; Jie Zhang; Monica L Acosta; Ilva D Rupenthal
Journal:  J Mol Med (Berl)       Date:  2018-12-08       Impact factor: 4.599

Review 2.  Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain.

Authors:  Marijke De Bock; Luc Leybaert; Christian Giaume
Journal:  Neurochem Res       Date:  2017-06-20       Impact factor: 3.996

Review 3.  Disentangling the Role of Astrocytes in Alcohol Use Disorder.

Authors:  Louise Adermark; M Scott Bowers
Journal:  Alcohol Clin Exp Res       Date:  2016-08-01       Impact factor: 3.455

Review 4.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 5.  Connexin channel and its role in diabetic retinopathy.

Authors:  Sayon Roy; Jean X Jiang; An-Fei Li; Dongjoon Kim
Journal:  Prog Retin Eye Res       Date:  2017-06-08       Impact factor: 21.198

6.  Synthesis and biological evaluation of S-lipidated lipopeptides of a connexin 43 channel inhibitory peptide.

Authors:  Sung-Hyun Yang; Connor A Clemett; Margaret A Brimble; Simon J O'Carroll; Paul W R Harris
Journal:  RSC Med Chem       Date:  2020-07-10

Review 7.  Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy.

Authors:  Ning-Ning Zhang; Yi Zhang; Zhen-Zhen Wang; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2022-02-10       Impact factor: 7.169

8.  Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.

Authors:  Yeri Kim; Jarred M Griffin; Mohd N Mat Nor; Jie Zhang; Peter S Freestone; Helen V Danesh-Meyer; Ilva D Rupenthal; Monica Acosta; Louise F B Nicholson; Simon J O'Carroll; Colin R Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 9.  Connexins and their channels in inflammation.

Authors:  Joost Willebrords; Sara Crespo Yanguas; Michaël Maes; Elke Decrock; Nan Wang; Luc Leybaert; Brenda R Kwak; Colin R Green; Bruno Cogliati; Mathieu Vinken
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-07-07       Impact factor: 8.250

10.  Inflammatory response in epilepsy is mediated by glial cell gap junction pathway (Review).

Authors:  Guangliang Wang; Jiangtao Wang; Cuijuan Xin; Jinyu Xiao; Jianmin Liang; Xuemei Wu
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.